Written by Cassian Vance
AXT Inc. (AXTI) has emerged as a fascinating, albeit highly volatile, play on the artificial intelligence infrastructure boom. As a material science company specializing in high-performance compound semiconductor substrates, AXT sits at the very foundation of the optical connectivity supply chain that powers modern AI data centers. With the explosive growth of hyperscale computing driving unprecedented demand for faster data transmission, the company’s indium phosphide (InP) wafers have become a critical enabler of the copper-to-optics transition. However, extreme valuation metrics, significant geopolitical exposure, and recent insider selling present a complex picture for investors evaluating this name at current levels.
Earnings Trough to Inflection Point
The first quarter of 2026 marked a decisive turning point for AXT. The company reported revenue of $26.9 million, representing a robust 39.1% year-over-year increase and a 17% sequential gain from the fourth quarter of 2025. This top-line performance surpassed the Street consensus of $26.7 million and was driven primarily by a surge in InP substrate sales, which accounted for $13.6 million of total revenue—more than half of the company’s output. Gallium arsenide contributed $5.4 million, while germanium substrates remained negligible at $0.2 million. Revenue from AXT’s consolidated raw material joint ventures added $7.6 million.
More impressively, AXT demonstrated substantial progress toward profitability. Non-GAAP gross margins expanded dramatically to 29.9%, a stark reversal from the negative 6.1% recorded in the year-ago quarter and a meaningful improvement from 21.5% in Q4 2025. The company reported a non-GAAP net loss of just $0.6 million, or $0.01 per share, beating analyst expectations of a $0.05 loss by 80%. On a GAAP basis, the net loss narrowed to $1.6 million ($0.03 per share), compared with $8.8 million ($0.20 per share) in Q1 2025.
Looking ahead, management has provided optimistic guidance for Q2 2026, projecting positive earnings per share between $0.06 and $0.08—signaling a return to structural profitability for the first time since the onset of China’s export control disruptions. Analysts now expect full-year 2026 EPS of approximately $0.20.
| Metric | Q1 2026 | Q4 2025 | Q1 2025 | YoY Change |
| Revenue | $26.9M | $23.0M | $19.4M | +39.1% |
| InP Revenue | $13.6M | $8.0M* | $9.1M* | +49.5% |
| Non-GAAP Gross Margin | 29.9% | 21.5% | -6.1% | +3,600 bps |
| Non-GAAP EPS | -$0.01 | -$0.05 | -$0.19 | +94.7% |
*Estimated based on quarterly product mix disclosures.
The Indium Phosphide Catalyst
The core investment thesis for AXT centers on the industry-wide transition from copper to optical interconnects in high-performance computing environments. As AI clusters scale to tens of thousands of GPUs, the bandwidth requirements for server-to-server and rack-to-rack communication exceed the physical limitations of traditional copper wiring. Indium phosphide is the substrate of choice for electro-absorption modulated lasers (EMLs) and silicon photonics devices used in 800G and 1.6T optical transceivers—the very components enabling AI data center connectivity at scale.
Management notes that the company’s InP backlog has reached a record high of over $60 million, more than doubling from Q2 2025 levels. CEO Morris Young stated on the Q1 earnings call that “scale-out” orders are expected to roughly double in 2026 and again in 2027, with a potential inflection from co-packaged optics (CPO) emerging in 2028–2029. AXT is broadening its customer base to include tier-1 laser manufacturers and optical transceiver module makers globally, moving beyond its historically China-centric customer mix.
To meet this demand trajectory, AXT completed a $632.5 million capital raise in April 2026—a transformative event for a company with trailing revenue under $100 million. The proceeds are earmarked for Tongmei’s InP capacity expansion, with plans to double output by year-end 2026 using existing brownfield facilities (requiring less than $30 million in CapEx). A further doubling in 2027, requiring $100–$150 million in greenfield construction, is under active consideration. A major focus of the expansion is the development of 6-inch InP wafers, which will be critical for next-generation EML and silicon photonics devices.
Geopolitical Fault Lines
Despite the compelling technological tailwinds, AXT’s operational structure introduces profound geopolitical risks that cannot be dismissed. The company manufactures all of its wafers in China through its subsidiary, Beijing Tongmei Xtal Technology. This vertical integration—which includes partial ownership in ten Chinese raw material suppliers producing gallium, germanium, pyrolytic boron nitride crucibles, and InP polycrystalline feedstock—provides significant cost advantages and secures access to critical elements that are themselves subject to export controls.
However, this reliance on China places AXT squarely in the crosshairs of escalating trade tensions. In February 2025, China added indium phosphide to its export control list, requiring AXT to secure government permits for every overseas customer shipment. While the company received its first InP export permit in late June 2025 and has successfully navigated the process since, the opaque and timing-volatile nature of these controls constrained Q4 2025 revenue below guidance and remains a persistent overhang. Additionally, U.S. tariffs on Chinese-made wafers climbed to 70% in 2025, effectively eliminating AXT’s North American revenue—which fell from 8% of total sales in 2024 to just 1% in Q1 2026.
The pending STAR Market IPO of Tongmei on the Shanghai Stock Exchange adds another layer of complexity. While the SSE approved the listing in July 2022, final CSRC approval remains outstanding. Chinese private equity investors hold a 7.28% redeemable noncontrolling interest in Tongmei valued at approximately $49 million—a potential cash obligation if the IPO fails to materialize.
Valuation: Priced for Perfection
The market has aggressively priced in AXT’s AI-driven potential. Over the past twelve months, the stock has delivered an astronomical return of nearly 5,000%, pushing its market capitalization to approximately $6.8 billion against trailing twelve-month revenues of $88.3 million. The stock recently traded near $105, with a 12-month range of $1.38 to $134.00. By any traditional valuation metric—price-to-sales of approximately 77x, negative P/E, and a price-to-book ratio that dwarfs semiconductor peers—the stock is extremely overvalued relative to current fundamentals.
This lofty valuation is further complicated by aggressive insider selling. Over the past six months, company insiders have executed 33 sales and zero open-market purchases. CEO Morris Young sold approximately 548,000 shares for $17.1 million, while CFO Gary Fischer sold 293,000 shares for $6.4 million. While insider selling does not always signal bearishness—particularly after a parabolic run—the absence of any insider buying is notable.
Analyst consensus remains cautious. The average price target of $22.80 is dramatically below the current share price, though this reflects the lag in coverage updates following the stock’s explosive move. Wedbush’s April 2026 target of $80 (Outperform) is the most current and still implies downside from recent levels.
Risks and Catalysts
Key Risks: The primary risks facing AXT investors include: (1) Chinese export permit uncertainty, which can unpredictably constrain shipments and revenue recognition; (2) escalating U.S.–China geopolitical tensions that could further restrict cross-border operations; (3) extreme valuation that leaves no margin for execution missteps; (4) significant dilution from the $632.5 million capital raise on a relatively small share base; and (5) competitive capacity additions from Sumitomo Electric (planning a 40% InP expansion by 2027) and JX Advanced Metals (20% expansion announced).
Key Catalysts: On the positive side, potential catalysts include: (1) the imminent return to GAAP profitability in Q2 2026; (2) successful doubling of InP capacity by year-end, supporting a $35 million quarterly InP revenue run-rate; (3) qualification wins with tier-1 global optical transceiver manufacturers; (4) the emerging CPO market opportunity in 2028–2029; (5) potential completion of the Tongmei STAR Market IPO, which could unlock substantial value; and (6) continued expansion of GaAs applications in autonomous vehicles and robotics.
Verdict
AXTI — HOLD
Price Target: $85.00
AXT’s technological positioning in the InP substrate market is undeniable, and its imminent return to profitability represents a genuine inflection point in the company’s trajectory. The secular demand drivers from AI data center optical connectivity are powerful and multi-year in nature. However, the extreme valuation—a $6.8 billion market cap on sub-$100 million in trailing revenue and negative earnings—leaves no margin for error. Any delay in capacity expansion, disruption in Chinese export permits, or broader macroeconomic cooling could trigger severe multiple compression. Current shareholders may wish to hold for the realization of the Q2 profitability milestone, but taking partial profits is advisable given the parabolic nature of the recent advance. New investors should wait for a more attractive entry point.
Comparable Verdicts
Coherent Corp. (COHR) — BUY
Price Target: $375.00
A much larger and more diversified player in the optical and materials space, Coherent offers a safer, more balanced approach to the AI optical networking theme. With a broad portfolio spanning datacom transceivers, laser components, and semiconductor materials (including InP and SiC substrates), Coherent provides exposure to the same secular tailwinds without the concentrated geopolitical risks inherent in AXT’s China-only manufacturing model. The company’s fiscal Q3 2026 results demonstrated strong execution, and the consensus BUY rating with a $369 average target reflects confidence in its diversified growth trajectory.
IQE plc (LSE: IQE) — HOLD
Price Target: 40 GBX
The UK-based compound semiconductor epitaxy specialist is a key player in the III-V materials supply chain, serving wireless, photonics, and infrared sensing markets. IQE stands to benefit from similar macro trends driving InP and GaAs demand, but has struggled with consistent execution and margin delivery over recent years. With full-year 2025 results due on May 28, 2026, the stock trades near 40p with limited analyst conviction. A clearer demonstration of sustained margin improvement and volume growth is required before a more bullish stance is warranted.
Disclosure: This article is for informational purposes only and does not constitute investment advice. The author holds no position in AXTI, COHR, or IQE. Past performance is not indicative of future results. Investors should conduct their own due diligence before making investment decisions.
